This trial is active, not recruiting.

Condition patients who are in need of short or long term rehabilitation due to neurological event (mainly stroke) or post orthopedic surgery
Treatment mind body therapy
Sponsor Tel-Aviv Sourasky Medical Center
Start date November 2009
End date November 2010
Trial size 30 participants
Trial identifier NCT01074788, tasmc-09-yl-0488, tasmc0488-09


The main goal of geriatric rehabilitation following an acute illness is rapid restoration of normal activity. The key elements are pain control, restoration of bowel functions, good sleep quality, appetite and general well-being, as well as return to pre illness physical capabilities. Emphasis has recently been placed on finding innovative multi-disciplinary methods that can improve the care of elderly people who had suffered an acute illness. The aim of this prospective study is to assess the effect of mind-body therapy(including guided imagery, relaxation techniques, mediation and touch therapy) as as an adjunct to medical and physical rehabilitation in geriatric patients.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model single group assignment
Masking open label
Primary purpose supportive care
mind body therapy
mind-body therapy includes guided imagery, relaxation techniques, mediation and touch therapy.

Primary Outcomes

effect on quality of life
time frame: 1 year

Secondary Outcomes

effect of treatment on rehabilitation
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. Inpatients,age 18 and above. 2. Getting standard rehabilitation therapy 3. Can fill an informed consent. Exclusion Criteria: 1. Medically unstable patients (uncontrolled heart failure,rapid AF, severe infection, constant need of oxygen therapy). 2. Demented patients who are unable to fill an informed consent

Trial information was received from ClinicalTrials.gov and was last updated in February 2010.
Information provided to ClinicalTrials.gov by Tel-Aviv Sourasky Medical Center.